22.11 Platform release now live!

We have just released the latest update to the Open Targets Platform — 22.11.

This release integrates new gene burden data for Parkinson’s disease, features updated classifications for clinical trial stop reasons, and displays variant functional consequences for Gene2Phenotype and Orphanet.

Key highlights for this release:

This release integrates 14,611,717 evidence strings to build 6,960,486 target-disease associations between 22,274 diseases and 62,678 targets from the following 22 public resources:

Additionally, the Platform now allows users to explore data on 12,854 drugs.

For more details, read the 22.11 blog post.